Applied Optoelectronics surged 9.1% intraday; bullish options rose as much as 165%
智通财经2026/10/09 13:52$Applied Optoelectronics (AAOI.US)$ shares rose by 9.1% during trading hours. The highest trading volume call option saw a price change of +165%, with a trading volume of 354 contracts. For more details, refer to the options page's ranking. Option prices are highly volatile; please be aware of the risks. Click to view the AAOI options chain.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cross-chain atomic transactions between Ethereum mainnet and L2
US Stock Movement | US clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) enters the US stock market, shares drop over 10% after opening
According to Jinse Finance, Retension Pharmaceuticals (RTSN.US) debuted on the US stock market on Friday and fell over 10% to $10.77 at press time, with an IPO price of $12. Retension Pharmaceuticals is a US-based clinical-stage biopharmaceutical company focused on developing innovative drugs for the treatment of hypertension and other cardiovascular diseases. The company's core investigational drug, RTN-001, is a new generation phosphodiesterase 5 (PDE5) inhibitor, primarily targeting patients with uncontrolled or resistant hypertension, and is currently undergoing a Phase IIb clinical trial. This drug works by enhancing nitric oxide signaling in blood vessels to promote vasodilation and lower blood pressure. The exclusive global development license comes from French pharmaceutical giant Sanofi (SNY.US).
Chevron has suspended production operations at five facilities in the U.S. Gulf region.
Chevron (CVX.US) has evacuated personnel and shut down production operations at five facilities in the US Gulf region, while another four offshore platforms continue production.
Crypto prices
More
